We are excited to share a new blog post on prescription drug advertising written by GREMAP research coordinator Lily Johns and published in the Interdisciplinary Assocation for Population Health Sciences (IAPHS) Blog. The article explores the possibility of a federal ban on prescription drug ads, also known as direct-to-consumer advertisements (DTCA), a policy that has been promoted by recently-appointed HHS Secretary RFK Jr. In the article, which is titled “Selling Health, Selling Illness, or Just Selling Drugs? A Look at a Potential Ban on Prescription Drug Ads”, Lily incorporates evidence from research and prior policies to provide further context to this potential ban and the—both positive and negative—impacts that it could have on public health. You can read the full article here.